Are you unsure whether Fragment Based Drug Discovery is a valid approach for your target?
Fragment Based Drug Discovery is now a well-established method to develop small molecule therapeutics for challenging drug targets. Orthosteric inhibitors, allosteric inhibitors (Asciminib) and Molecular Glues (ImIDs) are just some of the mechanisms of action…
A Fast Route to Success in Molecular Glue Discovery
Are you developing or thinking of developing small molecule therapeutics against a really challengin target? If so, does one of these scenarios describe your situation?
– You are trying to determine which small molecule approach is best for your target (orthosteric/allosteric inhibitor, degrader…
ZoBio Launches Comprehensive DEL Hit Discovery Service for Challenging Targets
LEIDEN, NL
ZoBio, a boutique problem-solving Contract Research Organization (CRO) specializing in early gene-to-lead discovery, today announced the launch of its comprehensive…
Expanding Isotopic Labeling in Mammalian Expression: Pushing the Boundaries on NMR Studies of Hard-to-Express Proteins
ZoBio is excited to expand its exclusive capability for making complex protein samples for drug discovery with 13C-methyl MILV isotopic labeling during HEK293 mammalian…